If interested in contacting any of the programs below for
mentorship, please contact Molly Astudillo at firstname.lastname@example.org
Bioengineering Initiative in the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Medical Center
The Bioengineering Initiative in the Sheikh Zayed Institute for
Pediatric Surgical Innovation at Children's National Medical Center
focuses on technology development for minimally invasive interventions.
The laboratory's research areas include pre-procedure planning,
intra-procedure guidance, and post-procedure assessment. Current topics
of interest include surgical planning for craniosynostosis and
hydronephrosis, image-guided navigation for orthopaedics, robotic
assistance for endoscopic procedures, surgical skill evaluation, and
nanotechnology for novel molecular imaging methods. The laboratory is
co-directed by Kevin Cleary, PhD, and Raymond Sze, MD and includes
engineers, computer scientists, surgeons, and radiologists.
Lead: Kevin Cleary, PhD
Johns Hopkins University
World-renowned for its medical research and advances, the Johns
Hopkins University includes a variety of research centers and CORE
facilities. Designed to encourage cutting-edge research in the areas of
medicine, genetics, technology and others, these facilities enable our
researchers to better medical treatments for a wide variety of health
The Interventional Radiology Research Animal Laboratory: The Interventional Radiology Research Laboratory occupies 5,000 square feet of space in the Traylor and adjoining Ross Research Buildings. The facility contains state-of-the-art single plane fluoroscopic, angiographic, and cineradiographic x-ray suites, x-ray c-arm cone beam CT (CBCT), animal clinic/exam room, animal surgical rooms, and an interventional radiology device fabrication laboratory. The two modern angiographic suites designed specifically for animal research provide single plane fluoroscopy with normal and high speed (90 frames/sec), digital subtraction angiography, rotational angiography and single film recording. The facility is equipped with a multiple angulation angiocardiographic table to facilitate procedures. Support equipment includes computerized physiological monitoring and recording systems, dual channel electromagnetic and ultrasonic blood flow meters, ventilators, infusion pumps, a gas anesthesia unit, defibrillator and crash cart, contrast media injectors, three ultrasound units with an array of transducers, ample laboratory counter space and general laboratory equipment.
Our research focuses on 3 major areas: Discovery and development of new cancer therapeutics designed to target the up-regulated tumor metabolism pathway; Study, assessment and development (both clinically and pre-clinically) of new drug delivery platforms including nanoparticles and liposomes; and finally development and validation of various imaging protocols to assess tumor response after loco-regional therapy for cancer.
Lead: Jeff Geschwind, MD, FSIR
Interventional Oncology Laboratory at Northwestern
The Interventional Oncology Laboratory, co-directed by Andrew
Larson and Reed Omary specializes in the pre-clinical development and
clinical translation of image-guided cancer therapies. Specific
research interests include the development of IO therapies for liver
and pancreatic cancer along with associated imaging techniques for
treatment planning and follow-up monitoring of therapy response.
Current multi-disciplinary research efforts include the development and
validation of innovative transcatheter approaches for targeted drug and
brachytherapy delivery (drug eluting microspheres, nanotechnology,
radioembolization microspheres), tissue ablation technology
(photothermal and irreversible electroporation approaches), and
targeted delivery of cellular and peptide-based immunotherapy.
Lead: Andrew Larson, PhD
Vascular and Interventional Translational Lab at Mayo Clinic
The Vascular and Interventional Translational Lab at Mayo
Clinic is interested in the developing translational therapies to treat
venous stenosis formation associated with hemodialysis graft failure
and developing nano imaging and nano drug delivery for acute kidney
injury. Consisting of an 800 square foot laboratory is complete with a
cell culture room and a microsurgical room with state of the art
molecular biology capabilities. There are two technicians and
three post doctoral fellows who work in the laboratory.
Lead: Sanjay Misra, MD, FSIR